ehat is glp 1 Glucagon-like peptide-1 Understanding GLP-1 medications

Understanding which drugs are approaching loss of exclusivity, which ANDA filings have been made, which Paragraph IV certifications are pending litigation, and which settlement agreements are volume-capping generic entry this is the data layer beneath the commercial dynamics

Available from: Accessed June 1, 2025

This underscores the necessity of continuous therapy to manage this chronic disease

These effects reflect indirect cardiovascular risk reduction and direct neurovascular actions, including enhanced endothelial function and reduced neuroinflammation (196, 200)

Acute Pancreatitis Incidence in Patients Initiating Glucagon-Like Peptide-1 Receptor Agonists for Obesity in a Large US Health Care System